You searched for "therapeutics"

422 results found

Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm

Surgery for nasal polyposis has evolved significantly in the last 30 years, and now the medical management may be on the cusp of a revolution. Biologics using monoclonal antibodies to target specific immune pathways have introduced a paradigm shift in...

The nice therapist effect: does the therapeutic relationship matter?

Quality of relationships is considered a core component of all speech and language therapy work, yet there is little agreement of what constitutes a therapeutic relationship. This study describes a scoping review to map existing evidence that has investigated this...

SmellTaste 2019

Report by: Katherine Haugh People affected by smell or taste disorders from around the world joined clinicians, scientists and patient advocates at SmellTaste2019 in Gainesville, Florida, in May 2019. Hosted by the University of Florida Centre for Smell and Taste...

Hyposalivation: a review of current and future treatments

Hyposalivation remains a stubbornly difficult condition to treat, but novel therapies may not be far away. Saliva has many essential functions, including aiding digestion and swallowing, lubrication, maintaining tooth integrity and antibacterial activity. When patients experience reduced saliva production (hyposalivation),...

Back to the future: aphasia therapy post stroke

When speech and language therapist first started working with people with stroke-related aphasia, they employed a general stimulation approach, the same with every patient they met. In the '70s this changed, and a more tailored approach was developed whereby therapists...

Treatment options for vestibular neuritis: systematic review and meta-analysis

Vestibular neuritis (VN) is the third most common cause of peripheral vertigo. VN has been postulated to have viral aetiology and historically it was treated with steroids, until 2011 when a Cochrane review demonstrated lack of robust evidence behind this...

Doing it for the men: diversifying the speech and language therapy profession

It is known that many health professions are dominated by females, particularly the allied health professions, such as speech and language therapy. This is more pronounced in the US than in the UK, Australia and other countries. The authors of...

A place for everything and everything in its place: the practicalities of randomised clinical trials

Will this pill cure tinnitus? Bonnie Millar describes one trial that has investigated the possibility whilst describing the path of drug trials in the UK. Background In the last quarter of 2014, a clinical trial (QUIET-1; ClinicalTrials.gov Identifier: NCT02315508) commenced...

2022 Hearing Technology Innovator Awards

Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, has announced a call for submissions for the third annual Hearing Technology Innovator Awards™. Through the annual awards programme, HHTM honours technological innovation...

BTA Tinnitus Conference 2022

British Tinnitus Association launches world’s largest online tinnitus conference for 2022 The British Tinnitus Association (BTA) has announced its annual tinnitus conference will once again take place virtually this year, from 26 to 30 September 2022. Following the success of...

Biologics for deafness

Cochlear implants and hearing aids are inherently limited in their ability to restore ‘natural’ hearing. Biological therapy to treat inner ear pathology still is evolving rapidly with several ongoing clinical trials, though none are available for clinical practice to date....

Valsalva manoeuvre treatment of otitis media with effusion in adults

Otitis media with effusion (OME) is common in children but has a low prevalence in adults. There is some evidence to advocate middle ear inflation as a successful treatment for children with OME. This form of treatment is also recommended...